Purchase Order 140D0425P0171
Award Date
9/29/25
Potential Completion Date
9/28/26
Potential Value
$79K
Funding Federal Agency
National Cancer Institute
Contracting Federal Agency
Interior Business Center
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
513210 - Software Publishers
PSC Category
DA10 - It And Telecom - Business Application/Application Development Software As A Service
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price purchase order was awarded to Illumina, Inc. by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for the deployment of two Illumina DRAGEN Server v4 systems and associated licenses. The total ceiling value of the contract is $200,500.00, with a period of performance through October 26, 2025. The original solicitation indicates that the NCI requires the DRAGEN processors to support its Whole Genome and Whole Exome Data Processing...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,000 purchase order to Illumina, Inc. to provide DRAGEN CS LVL 1 LICENSE THROUGHPUT OF 100,000GB under contract number E21C6L5011010032. The one-year contract, which runs from July 2025 through July 2026, calls for Illumina to deliver genomic sequencing software licensing and throughput on a firm fixed price basis, to be billed quarterly in arrears. As the prime...
This federal contract award, valued at $15,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a DRAGEN CS Level 1 License with a throughput of 100,000GB, with a period of performance from July 25, 2024 to July 24, 2025. The contract is a firm fixed price purchase order and does not have a set-aside designation. Illumina has previously received prime federal...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at twenty thousand two hundred ninety-eight dollars and ninety-nine cents ($20,298.99) to Illumina, Inc. to provide a one-year license for the DRAGEN CS Level 1 throughput of one hundred thousand gigabytes. The license will be delivered under a thirteen point six month period running from May seventh, two thousand twenty-one through...
This is a $25,000.00 firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for an annual license of Illumina's BaseSpace Correlation Engine software for academic and large lab use. The contract does not have a set-aside designation. Illumina has been awarded numerous prime federal contracts and...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the provision of a DRAGEN Appliance for HIVE. The total potential value of the contract is $210,454.80, with a completion date of September 21, 2024. Illumina has a history of providing sequencing instruments, consumables, and support services to various federal agencies, including the...
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and related products. The contract, valued at $23,105.55, is for the procurement of computer software and a software upgrade for a methylation screening array. The contract has an ultimate completion date of May 30, 2025 and does not utilize any set-aside designations. Illumina, a leading provider of...
This contract was awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $24,797.20 firm-fixed-price delivery order is for Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. No set-aside was used. Illumina has a history of providing these types of products and services to...
This is a $17,508.94 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is not set aside for any special designation. Illumina has previously been awarded prime federal contracts and subcontracts by agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems, consumables, and...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc. for a DRAGEN Appliance for HIVE, including the license, platform, installation, and support plan. The contract has a potential value of $255,450.00 and a completion date of August 28, 2024. Illumina, a manufacturer of goods, has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of Health, Centers for...